Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hepatitis

Free Subscription 05.10.2026 1 BMC Gastroenterol 2 Clin Infect Dis 1 Gut 3 Hepatology 2 J Med Virol 2 J Viral Hepat 1 Lancet 1 Transplant Proc 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. WANG CX, Kang J, Zhang JW, Yuan XY, et al
   Clinical characteristics of metabolic dysfunction-associated steatotic liver disease and its association with significant liver fibrosis in hospitalized patients with chronic hepatitis B: a single-center retrospective cross-sectional study.
   BMC Gastroenterol. 2026;26:588.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. SHI MA, Han J, Albahra R, Machicao MF, et al
   Hepatitis B Vaccination for Liver Transplant Recipients in the United States: A National Cohort Study.
   Clin Infect Dis. 2026 Sep 29:ciag585. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KRISHNAN G, Kottilil S
   Closing the Hepatitis B Vaccination Gap in Liver Transplant Candidates.
   Clin Infect Dis. 2026 Sep 29:ciag586. doi: 10.1093.
   PubMed        
   
   

   
   Gut

4. LAU DT, Su YH, Guo H
   Reply to 'DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?'.
   Gut. 2026 Sep 29:gutjnl-2026-340701. doi: 10.1136/gutjnl-2026-340701.
   PubMed        
   
   

   
   Hepatology

5. JUCOV A, Conway B, Feld JJ, Hamid S, et al
   Efficacy and safety of an 8-week bemnifosbuvir and ruzasvir regimen in chronic hepatitis C: Results from a Phase 2 study.
   Hepatology. 2026 Oct 2. doi: 10.1097/HEP.0000000000001871.
   PubMed         Abstract available
   
   
6. WU Q, Beer A, Xu Z, Zhang Z, et al
   Reciprocal cross-species infection potential of human and domestic cat hepatitis B viruses.
   Hepatology. 2026 Oct 1. doi: 10.1097/HEP.0000000000001877.
   PubMed         Abstract available
   
   
7. DASARATHY S, Karpyak VM, Arab JP, Singal AK, et al
   Therapies for alcohol use disorder in alcohol-associated hepatitis clinical trials: Integrated trial design with a composite clinical outcome as the primary endpoint.
   Hepatology. 2026 Sep 28. doi: 10.1097/HEP.0000000000001878.
   PubMed        
   
   

   
   J Med Virol

8. ZHANG Y, Deng L, Yang R, Xiong Y, et al
   Association Between EBV Lytic Replication and Liver Injury in Patients With HBeAg-Negative Chronic HBV Infection.
   J Med Virol. 2026;98:e71071.
   PubMed         Abstract available
   
   
9. SHIN YE, Kim JY, Yoo JJ, Kim SG, et al
   High Treatment Adherence Is Associated With Lower Observed HCC Risk in Patients With Chronic Hepatitis B and Cirrhosis: A Nationwide Claims-Based Cohort Study.
   J Med Virol. 2026;98:e71167.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

10. REN J, Ji R, Zhu Z, Ren X, et al
    Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021.
    J Viral Hepat. 2026;33:e70236.
    PubMed         Abstract available
    
    
11. GUNASEKARAN V, Arun Babu T
    Can Point-of-Care Ultrasound for Hepatitis (PUSH) Protocol Be Considered an HCC Screening Tool? Methodological Considerations From a Validation Study.
    J Viral Hepat. 2026;33:e70239.
    PubMed        
    
    

    
    Lancet

12. GOEL A, Rungta S, Kumar V, Shalimar, et al
    8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.
    Lancet. 2026 Sep 30:S0140-6736(26)01380-2. doi: 10.1016/S0140-6736(26)01380.
    PubMed         Abstract available
    
    

    
    Transplant Proc

13. SUMMERS BB
    A Case of Graft-Versus-Host Disease in a Liver Transplant Recipient Receiving an HCV NAT Positive Organ: Does HCV NAT Matter?
    Transplant Proc. 2026 Sep 26:S0041-1345(26)00451.
    PubMed         Abstract available
    
    

    
    Vaccine

14. SEMPERE L, Almenta I, Barrenengoa J, Gutierrez A, et al
    Corrigendum to 'Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease' [Vaccine 31 (2013) 3065-3071].
    Vaccine. 2026 Sep 28:129140. doi: 10.1016/j.vaccine.2026.129140.
    PubMed        
    
    
15. MONTES CAMINO LM, Aldea M, Martinez C, Garcia-Basteiro AL, et al
    Evaluation of the immunogenicity of hepatitis B vaccination in hematopoietic stem cell transplant recipients vaccinated with a hexavalent vaccine compared with patients vaccinated with a combined hepatitis A and B vaccine.
    Vaccine. 2026;93:129183.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum